| Literature DB >> 28803548 |
Laura Benschop1, Sarah Schalekamp-Timmermans2, Jeanine E Roeters van Lennep3, Vincent W V Jaddoe4,5, Tien Yin Wong6, Carol Y Cheung6,7, Eric A P Steegers2, M Kamran Ikram4,8.
Abstract
BACKGROUND: Changes in the microvasculature associated with pre-eclampsia and gestational hypertension have been proposed as a potential pathway in the development of cardiovascular disease. We examined whether gestational hypertensive disorders, such as pre-eclampsia and gestational hypertension, are related to the maternal retinal microvasculature status after pregnancy.Entities:
Keywords: Microvessels; Post-pregnancy retinal imaging; Pre-eclampsia; Pregnancy induced hypertension
Mesh:
Year: 2017 PMID: 28803548 PMCID: PMC5554975 DOI: 10.1186/s12916-017-0917-2
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Fig. 1Flowchart of women involved in the study
Subject characteristics by gestational hypertensive disorder (n = 3391)
| Normotensive pregnancy | GH | PE |
| |
|---|---|---|---|---|
| ( | ( | ( | ||
| Maternal characteristics (pregnancy) | ||||
| Age at enrollment (years) | 30.1 (5.1) | 30.4 (5.1) | 29.4 (5.5) | 0.44 |
| Gestational age at enrollment (weeks) | 13.9 (10.9, 22.2) | 13.4 (10.1, 22.9) | 13.8 (10.3, 22.5) | 0.15 |
| Height (cm) | 166.6 (7.4) | 168.0 (7.3) | 165.3 (6.8) | 0.03 |
| Pre-pregnancy weight (kg) | 64.0 (50.0, 87.0) | 70.0 (54.0, 114.4) | 68.0 (53.2, 105.0) | <0.001 |
| Pre-pregnancy body mass index (kg/m2) | 22.7 (18.7, 31.5) | 25.2 (20.0, 40.2) | 24.4 (19.2, 37.2) | <0.001 |
| Weight at enrollment (kg) | 67.0 (52.8, 91.1) | 75.0 (56.3, 112.0) | 70.0 (52.0, 110.4) | <0.001 |
| Systolic blood pressure at enrollment (mmHg) | 114.8 (11.7) | 126.0 (13.1) | 120.4 (12.9) | <0.001 |
| Diastolic blood pressure at enrollment (mmHg) | 67.3 (9.0) | 76.7 (11.3) | 74.3 (9.9) | <0.001 |
| Primiparous (no., %) | 1894 (60.0) | 110 (75.9) | 51 (81.0) | <0.001 |
| Non-European ethnicity (no., %) | 1267 (40.8) | 42 (29.0) | 30 (47.6) | 0.005 |
| Lower educational level (no., %) | 272 (9.2) | 11 (7.9) | 6 (10.0) | 0.02 |
| Smoking (no., %) | 749 (26.6) | 43 (32.1) | 13 (21.3) | 0.29 |
| Pregnancy outcomes | ||||
| Gestational age at birth (weeks) | 40.1 (37.1, 42.1) | 40.1 (37.2, 42.1) | 38.6 (30.9, 41.5) | <0.001 |
| Birth weight (g) | 3442.1 (539.8) | 3432.8 (578.6) | 2889.3 (877.4) | <0.001 |
| Small for gestational age < p10 (no., %) | 296 (9.3) | 20 (13.8) | 17 (27.0) | <0.001 |
| Male sex (no., %) | 1624 (51.0) | 76 (52.4) | 25 (39.7) | 0.19 |
Values are percentages for categorical variables, means (SD) for continuous variables with a normal distribution, or medians (90% range) for continuous variables with a skewed distribution. Differences in baseline characteristics were tested using Student’s t test, ANOVA, Kruskal-Wallis, and chi-square tests. Presented values are not imputed
Subject characteristics 6 years after index pregnancy by gestational hypertensive disorder (n = 3391)
| Normotensive Pregnancy | GH | PE |
| |
|---|---|---|---|---|
| ( | ( | ( | ||
| Maternal characteristics (follow-up) | ||||
| Age (years) | 36.7 (5.1) | 37.1 (4.9) | 36.0 (5.5) | 0.38 |
| Visit interval (years) | 6.2 (5.7, 7.4) | 6.1 (5.7, 7.6) | 6.0 (5.7, 7.5) | 0.30 |
| Systolic blood pressure (mmHg) | 118.1 (12.0) | 128.4 (17.6) | 126.5 (15.8) | <0.001 |
| Diastolic blood pressure (mmHg) | 70.0 (9.3) | 78.2 (12.0) | 78.5 (12.4) | <0.001 |
| Mean arterial pressure (mmHg) | 86.0 (9.6) | 95.0 (13.2) | 94.5 (12.9) | <0.001 |
| Hypertension (no., %) | 203 (6.4) | 39 26.9) | 15 (23.8) | <0.001 |
| Primigravid (no., %) | 225 (10.1) | 19 (17.0) | 9 (22.0) | 0.003 |
| Medication (no., %) | ||||
| Cholesterol-lowering medication | 8 (0.3) | 1 (0.7) | 0 (0.0) | 0.55 |
| Glucose-lowering medication | 13 (0.4) | 2 (1.4) | 1 (1.6) | 0.11 |
| Anti-hypertensives | 36 (1.1) | 10 (6.9) | 4 (6.3) | <0.001 |
| Cardiovascular medication | 43 (1.4) | 10 (6.9) | 4 (6.3) | <0.001 |
| Combined | 54 (1.7) | 11 (7.6) | 5 (7.9) | <0.001 |
| Smoking (no., %) | 420 (18.9) | 21 (18.9) | 3 (7.3) | 0.17 |
| Retinal arteriolar caliber (μm) | 145.8 (16.9) | 141.9 (17.8) | 137.8 (14.4) | <0.001 |
| Retinal venular caliber (μm) | 207.1 (22.5) | 208.6 (22.5) | 203.8 (19.0) | 0.36 |
| Retinal arteriolar venular ratio | 0.71 (0.07) | 0.68 (0.07) | 0.68 (0.06) | <0.001 |
| Weight (kg) | 68.6 (53.6, 97.8) | 77.0 (58.8, 121.1) | 73.5 (53.3, 120.7) | <0.001 |
| Body mass index (kg/m2) | 24.5 (19.7, 34.5) | 27.7 (21.3, 45.5) | 27.6 (19.6, 43.9) | <0.001 |
Values are percentages for categorical variables, means (SD) for continuous variables with a normal distribution, or medians (90% range) for continuous variables with a skewed distribution. Differences in baseline characteristics were tested using Student’s t test, ANOVA, Kruskal-Wallis, and chi-square tests. Values are not imputed
Associations of gestational hypertensive disorders with retinal vascular calibers 6 years after index pregnancy (n = 3391)
| Normotensive pregnancy ( | Gestational hypertension ( |
| Pre-eclampsia ( |
| |
|---|---|---|---|---|---|
| Retinal arteriolar caliber (SDS) | |||||
| Full model |
| –0.20 (–0.34, –0.05) | 0.007 | –0.40 (–0.62, –0.19) | 0.0002 |
| Retinal venular caliber (SDS) | |||||
| Full model |
| 0.22 (0.07–0.36) | 0.003 | 0.08 (–0.13, 0.30) | 0.45 |
CI confidence interval, Ref reference, SDS standard deviation score
Values are regression coefficients (95% CI) and are based on linear regression. Estimates are from multiple imputed data. Full model: adjusted for maternal age at enrollment, ethnicity, educational level at intake, smoking at intake, and pre-pregnancy BMI. Additionally, we adjusted for retinal venular caliber when assessing the outcome retinal arteriolar caliber and vice versa
The mediation role of mean arterial pressure at the time of retinal imaging in the association of gestational hypertensive disorders with retinal vascular calibers 6 years after index pregnancy (n = 3391)
| Normotensive pregnancy ( | Gestational hypertension ( |
| Pre-eclampsia ( |
| |
|---|---|---|---|---|---|
| Retinal arteriolar caliber (SDS) | |||||
| Total effect |
| –0.20 (–0.35, –0.05) | 0.01 | –0.41 (–0.62, –0.21) | <0.001 |
| Direct effect |
| –0.01 (–0.14, 0.13) | 0.94 | –0.21 (–0.41, –0.02) | 0.03 |
| Mediated effect |
| –0.20 (–0.26, –0.13) | <0.001 | –0.20 (–0.29, –0.11) | <0.001 |
| Retinal venular caliber (SDS) | |||||
| Total effect |
| 0.22 (0.08, 0.36) | <0.001 | 0.08 (–0.09, 0.27) | 0.39 |
| Direct effect |
| 0.16 (0.02, 0.30) | 0.02 | 0.03 (–0.14, 0.22) | 0.76 |
| Mediated effect |
| 0.06 (0.03, 0.09) | <0.001 | 0.05 (0.02, 0.09) | <0.001 |
CI confidence interval, Ref reference, SDS standard deviation score, BMI body mass index
Values are regression coefficients (95% CI) and are based on mediation analysis. Values are adjusted for maternal age at enrollment, ethnicity, educational level at intake, smoking at intake, and pre-pregnancy BMI. Additionally, we adjusted for retinal venular caliber when assessing the outcome retinal arteriolar caliber and vice versa